Asklepios BioPharmaceutical, Inc. (AskBio) is a clinical-stage leader in gene therapy using adeno-associated viruses (AAV), focused on improving the lives of patients with rare and other serious diseases. AskBio has built a portfolio of therapeutic programs, AAV manufacturing, and proprietary technology. Its therapeutic focus includes neuromuscular, CNS, cardiovascular, and metabolic diseases, with ongoing clinical trials for Pompe disease, Parkinson’s disease, and congestive heart failure.
CEOs
Sheila Mikhail and Jude Samulski
WEBSITE
https://www.askbio.com/
EXITED COMPANY
2016–2020 (Acquired by Bayer)
DETAILS
AskBio Headquarters
20 T.W. Alexander Drive, Suite 110
Research Triangle Park, NC 27709
